The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Renal cell carcinoma
Open accessAbstract
Renal Cell Carcinoma (RCC) has the highest mortality rate of the genitourinary cancers and the incidence of RCC has risen steadily. If detected early, RCC is curable by surgery although a minority are at risk of recurrence. Increasing incidental detection and an ageing population has led to active surveillance as an option for patients with small renal masses. RCC is heterogeneous and comprises several histological cell types with different genetics, biology and behavior. The identification of the genes predisposing to inherited syndromes with RCC has provided much of our knowledge of the molecular basis of early sporadic RCC. Many of the oncogenes and tumor suppressor genes that are mutated leading to pathway dysregulation in RCC remain to be elucidated. Global studies of copy number, gene sequencing, gene expression, miRNA expression and gene methylation in primary RCC will lead towards this goal. The natural history of RCC indicated by candidate precursor lesions, multifocal or bilateral disease, growth rate of small renal masses under surveillance, and high risk populations provide insight into the behavior of this disease. The use of molecular markers for early detection and prognosis merits more attention with ongoing advances in omics technologies. This review focuses on early RCC, that is disease confined within the renal capsule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Guideline for Management of the Clinical T1 Renal Mass
Campbell, S. C., Novick, A. C., Belldegrun, A., Blute, M. L., Chow, G. K., Derweesh, I. H., Faraday, M. M., Kaouk, J. H., Leveillee, R. J., Matin, S. F., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.004 · Cited by 1,831
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
Cohen, H. T., & McGovern, F. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043172 · Cited by 1,554
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Schmidt, L., Duh, F.-M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., et al. (1997) · Nature Genetics · doi:10.1038/ng0597-68 · Cited by 1,524
The Heidelberg classification of renal cell tumours
Kovacs, G., Akhtar, M., Beckwith, B. J., Bugert, P., Cooper, C. S., Delahunt, B., Eble, J. N., Fleming, S., Ljungberg, B., Medeiros, L. J., et al. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199710)183:2<131::aid-path931>3.0.co;2-g · Cited by 1,354
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Dalgliesh, G. L., Furge, K., Greenman, C., Chen, L., Bignell, G., Butler, A., Davies, H., Edkins, S., Hardy, C., Latimer, C., et al. (2010) · Nature · doi:10.1038/nature08672 · Cited by 1,173 · cited 7×
“This work provided arationaleforthe use of VEGF-inhibitors as therapy for RCC. Interestingly, point mutation of HIF1A was found in 3 of 101 clear cell RCC, two of which also had VHL mutations [18].”
InfluentialHigh-throughput oncogene mutation profiling in human cancer
Thomas, R. K., Baker, A. C., DeBiasi, R. M., Winckler, W., LaFramboise, T., Lin, W. M., Wang, M., Feng, W., Zander, T., MacConaill, L. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1975 · Cited by 988
Nickerson, M. L., Warren, M. B., Toro, J. R., Matrosova, V., Glenn, G., Turner, M. L., Duray, P., Merino, M., Choyke, P., Pavlovich, C. P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00104-6 · Cited by 940
Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.
Delahunt, B., & Eble, J. N. (1997) · PubMed · Cited by 714
Obesity, Hypertension, and the Risk of Kidney Cancer in Men
Chow, W.-H., Gridley, G., Fraumeni, J. F., & Järvholm, B. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431804 · Cited by 668
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
Cairns, P., Polascik, T. J., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., et al. (1995) · Nature Genetics · doi:10.1038/ng1095-210 · Cited by 627
Self-citationAnalysis of adenomatous polyposis coli promoter hypermethylation in human cancer.
Esteller, M., Sparks, A. B., Toyota, M., Sánchez‐Céspedes, M., Capellá, G., Peinado, M. A., González, S., Tarafa, G., Sidransky, D., Meltzer, S. J., et al. (2000) · PubMed · Cited by 536
Toro, J. R., Wei, M.-H., Glenn, G. M., Weinreich, M., Toure, O., Vocke, C., Turner, M., Choyke, P., Merino, M. J., Pinto, P. A., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.054304 · Cited by 513
Novel mutations of the MET proto-oncogene in papillary renal carcinomas
Schmidt, L., Junker, K., Nakaigawa, N., Kinjerski, T., Weirich, G., Miller, M., Lubensky, I., Neumann, H. P., Brauch, H., Decker, J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202547 · Cited by 497
HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<417::aid-humu8>3.0.co;2-k · Cited by 479
Gene Signatures of Progression and Metastasis in Renal Cell Cancer
Jones, J., Otu, H., Spentzos, D., Kolia, S., Inan, M., Beecken, W. D., Fellbaum, C., Gu, X., Joseph, M., Pantuck, A. J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2225 · Cited by 447
Tissue microarrays for gene amplification surveys in many different tumor types.
Schraml, P., Kononen, J., Bubendorf, L., Moch, H., Bissig, H., Nocito, A., Mihatsch, M. J., Kallioniemi, O., & Sauter, G. (1999) · PubMed · Cited by 433
HOCK, L. M., LYNCH, J., & BALAJI, K. C. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65382-7 · Cited by 420
Beroukhim, R., Brunet, J.-P., Di Napoli, A., Mertz, K. D., Seeley, A., Pires, M. M., Linhart, D., Worrell, R. A., Moch, H., Rubin, M. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0146 · Cited by 412
Takahashi, M., Rhodes, D. R., Furge, K. A., Kanayama, H.-O., Kagawa, S., Haab, B. B., & Teh, B. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171209998 · Cited by 403
The von Hippel-Lindau Tumor Suppressor Protein and Clear Cell Renal Carcinoma
Kaelin, W. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1865 · Cited by 336
Identification of a tumor‐initiating stem cell population in human renal carcinomas
Bussolati, B., Bruno, S., Grange, C., Ferrando, U., & Camussi, G. (2008) · The FASEB Journal · doi:10.1096/fj.08-102590 · Cited by 336
Cytogenetics of papillary renal cell tumors
Kovacs, G., Fuzesi, L., Emanuel, A., & Kung, H. (1991) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.2870030403 · Cited by 320
Expression Profiling of Renal Epithelial Neoplasms
Young, A. N., Amin, M. B., Moreno, C. S., Lim, S. D., Cohen, C., Petros, J. A., Marshall, F. F., & Neish, A. S. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64120-x · Cited by 311
Speicher, M. R., Schoell, B., du Manoir, S., et al. (1994) · PubMed · Cited by 294
Zhuang, Z., Park, W.-S., Pack, S., Schmidt, L., Vortmeyer, A. O., Pak, E., Pham, T., Weil, R. J., Candidus, S., Lubensky, I. A., et al. (1998) · Nature Genetics · doi:10.1038/1727 · Cited by 291
Nakada, C., Matsuura, K., Tsukamoto, Y., Tanigawa, M., Yoshimoto, T., Narimatsu, T., Nguyen, L., Hijiya, N., Uchida, T., Sato, F., et al. (2008) · The Journal of Pathology · doi:10.1002/path.2437 · Cited by 269
Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA Microarray
Higgins, J. P. T., Shinghal, R., Gill, H., Reese, J. H., Terris, M., Cohen, R. J., Fero, M., Pollack, J. R., van de Rijn, M., & Brooks, J. D. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63887-4 · Cited by 260
Lubensky, I. A., Schmidt, L., Zhuang, Z., Weirich, G., Pack, S., Zambrano, N., Walther, M. M., Choyke, P., Linehan, W. M., & Zbar, B. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65147-4 · Cited by 256
A Molecular Classification of Papillary Renal Cell Carcinoma
Yang, X. J., Tan, M.-H., Kim, H. L., Ditlev, J. A., Betten, M. W., Png, C. E., Kort, E. J., Futami, K., Furge, K. A., Takahashi, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0533 · Cited by 232
Jung, M., Mollenkopf, H., Grimm, C., Wagner, I., Albrecht, M., Waller, T., Pilarsky, C., Johannsen, M., Stephan, C., Lehrach, H., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00705.x · Cited by 229
Identification of a MicroRNA Panel for Clear-cell Kidney Cancer
Juan, D., Alexe, G., Antes, T., Liu, H., Madabhushi, A., Delisi, C., Ganesan, S., Bhanot, G., & Liou, L. S. (2010) · Urology · doi:10.1016/j.urology.2009.10.033 · Cited by 225
THE RELATIONSHIP BETWEEN RENAL TUMOR SIZE AND METASTASES IN PATIENTS WITH VON HIPPEL-LINDAU DISEASE
DUFFEY, B. G., CHOYKE, P. L., GLENN, G., GRUBB, R. L., VENZON, D., LINEHAN, W. M., & WALTHER, M. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000132127.79974.3f · Cited by 216
Hoque, M. O., Begum, S., Topaloglu, O., Jeronimo, C., Mambo, E., Westra, W. H., Califano, J. A., & Sidransky, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0799 · Cited by 213
Uncommon and recently described renal carcinomas
Srigley, J. R., & Delahunt, B. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.70 · Cited by 209
Searching for the hereditary causes of renal-cell carcinoma
Pavlovich, C. P., & Schmidt, L. S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1364 · Cited by 209
Epidemiology, Clinical Staging, and Presentation of Renal Cell Carcinoma
DeCastro, G. J., & McKiernan, J. M. (2008) · Urologic Clinics of North America · doi:10.1016/j.ucl.2008.07.005 · Cited by 199
Marshall, F. F. (2005) · Journal of Urology · doi:10.1097/01.ju.0000187488.30867.11 · Cited by 191
Lubensky, I. A., Gnarra, J. R., Bertheau, P., Walther, M. M., Linehan, W. M., & Zhuang, Z. (1996) · PubMed Central · Cited by 187
Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer.
Wilhelm, M., Veltman, J. A., Olshen, A. B., Jain, A. N., Moore, D. H., Presti, J. C., Kovács, G., & Waldman, F. M. (2002) · PubMed · Cited by 183
Molecular subclassification of kidney tumors and the discovery of new diagnostic markers
Takahashi, M., Yang, X. J., Sugimura, J., Backdahl, J., Tretiakova, M., Qian, C.-N., Gray, S. G., Knapp, R., Anema, J., Kahnoski, R., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206869 · Cited by 183
Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers
Cairns, P., Evron, E., Okami, K., Halachmi, N., Esteller, M., Herman, J. G., Bose, S., Wang, S. I., Parsons, R., & Sidransky, D. (1998) · Oncogene · doi:10.1038/sj.onc.1201855 · Cited by 180
Self-citationVasselli, J. R., Shih, J. H., Iyengar, S. R., Maranchie, J., Riss, J., Worrell, R., Torres-Cabala, C., Tabios, R., Mariotti, A., Stearman, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131754100 · Cited by 175
Urakami, S., Shiina, H., Enokida, H., Kawakami, T., Kawamoto, K., Hirata, H., Tanaka, Y., Kikuno, N., Nakagawa, M., Igawa, M., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2468 · Cited by 172
Contemporary approach to the classification of renal epithelial tumors.
Reuter, V. E., & Presti, J. C. (2000) · PubMed · Cited by 171
Overexpression of KIT in chromophobe renal cell carcinoma
Yamazaki, K., Sakamoto, M., Ohta, T., Kanai, Y., Ohki, M., & Hirohashi, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206153 · Cited by 160
Promoter Hypermethylation Profile of Kidney Cancer
Dulaimi, E., de Cáceres, I. I., Uzzo, R. G., Al‐Saleem, T., Greenberg, R. E., Polascik, T. J., Babb, J. S., Grizzle, W. E., & Cairns, P. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0175 · Cited by 157
Self-citationKiuru, M. H., Lehtonen, R., Arola, J. T., Salovaara, R., Järvinen, H., Aittomäki, K., Sjöberg, J., Visakorpi, T., Knuutila, S., Isola, J. J., et al. (2002) · PubMed · Cited by 156
Identification of Novel Target Genes by an Epigenetic Reactivation Screen of Renal Cancer
de Cáceres, I. I., Dulaimi, E., Hoffman, A. M., Al‐Saleem, T., Uzzo, R. G., & Cairns, P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3365 · Cited by 154
Self-citationInactivation of BHD in sporadic renal tumors.
Khoo, S. K., Kahnoski, K., Sugimura, J., Petillo, D., Chen, J., Shockley, K., Ludlow, J. W., Knapp, R., Giraud, S., Richard, S., et al. (2003) · PubMed · Cited by 143
Fischer, J., Palmedo, G., von Knobloch, R., Bugert, P., Prayer-Galetti, T., Pagano, F. C., & Kovács, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201983 · Cited by 141
Dahl, E., Wiesmann, F., Woenckhaus, M., Stoehr, R., Wild, P. J., Veeck, J., Knüchel, R., Klopocki, E., Sauter, G., Simon, R., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210345 · Cited by 137
Linehan, W. M., & Zbar, B. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.006 · Cited by 129
Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.
Battagli, C., Uzzo, R. G., Dulaimi, E., de Cáceres, I. I., Krassenstein, R., Al‐Saleem, T., Greenberg, R. E., & Cairns, P. (2003) · PubMed · Cited by 120
Self-citationMolecular differential diagnosis of renal cell carcinomas by microsatellite analysis.
Bugert, P., & Kovács, G. (1996) · Europe PMC (PubMed Central) · Cited by 119
Considerations When Analyzing the Methylation Status of PTEN Tumor Suppressor Gene
Zysman, M., Chapman, W. B., & Bapat, B. V. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64902-4 · Cited by 110
Prevention and Early Detection of Ovarian Cancer: Mission Impossible?
Bast, R. C., BREWER, M. A., Zou, C., Hernandez, M. A., Daley, M., Ozols, R. F., Lu, K. H., Lü, Z., Badgwell, D. B., Mills, G. B., et al. (2007) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-37696-5_9 · Cited by 106
Schullerus, D., Herbers, J., Chudek, J. T., Kanamaru, H., & Kovacs, G. (1997) · The Journal of Pathology · Cited by 106
Mock, H., Sauter, G., Buchholz, N. P. N., Gasser, T. C., Bubendorf, L., Waldman, F., & Mihatsch, M. J. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90198-2 · Cited by 100
Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
Cairns, P., Tokino, K., Eby, Y. J., & Sidransky, D. (1995) · PubMed · Cited by 98
Self-citationComprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.
Thrash-Bingham, C., Greenberg, R. E., Howard, S., Bruzel, A., Bremer, M., Goll, A., Salazar, H., Freed, J. J., & Tartof, K. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2854 · Cited by 91
Campbell, L., Gumbleton, M., & Griffiths, D. F. R. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601359 · Cited by 88
Gene methylation and early detection of genitourinary cancer: the road ahead
Cairns, P. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2170 · Cited by 84
Self-citationRohan, S. M., Tu, J. J., Kao, J., Mukherjee, P., Campagne, F., Zhou, X., Hyjek, E. M., Alonso, M. A., & Chen, Y. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1268 · Cited by 84
Prognostic factors and selection for clinical studies of patients with kidney cancer
Lam, J. S., Klatte, T., Kim, H. L., Patard, J., Breda, A., Zisman, A., Pantuck, A. J., & Figlin, R. A. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.08.003 · Cited by 81
Frequent Loss of Chromosome Arms 8p and 13q in Collecting Duct Carcinoma (CDC) of the Kidney
Schoenberg, M., Brooks, J. D., Marshall, F. F., Epstein, J. I., Isaacs, W. B., Cairns, P., & Sidransky, D. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870120115 · Cited by 77
Self-citationda Silva, N. F., Gentle, D., Hesson, L. B., Morton, D. G., Latif, F., & Maher, E. R. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.11.820 · Cited by 73
Smoking Cessation and Renal Cell Carcinoma
Parker, A. S. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(02)00271-5 · Cited by 61
Precancerous Lesions in the Kidney
van Poppel, H., Nilsson, S. F., Ferran Algaba, B., Bergerheim, U. S. R., Cin, P. D., Fleming, S., Hellsten, S., Kırkalı, Z., Klotz, L. H., Lindblad, P., et al. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590050509887 · Cited by 60
Identification of novel VHL target genes and relationship to hypoxic response pathways
Maina, E. N., Morris, M. R., Zatyka, M., Raval, R. R., Banks, R. E., Richards, F. M., Johnson, C. M., & Maher, E. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208649 · Cited by 57
Epigenetics of Kidney Cancer And Bladder Cancer
Hoffman, A. M., & Cairns, P. (2011) · Epigenomics · doi:10.2217/epi.10.64 · Cited by 54
Self-citationFurge, K. A., Tan, M.-H., Dykema, K. J., Kort, E. J., Stadler, W. M., Yao, X., Zhou, M., & Teh, B. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210256 · Cited by 53
Nagy, A., Zoubakov, D., Stupar, Z., & Kovács, G. (2004) · International Journal of Cancer · doi:10.1002/ijc.11694 · Cited by 49
The genetic basis of renal cell carcinoma
Pavlovich, C. P., Schmidt, L. S., & Phillips, J. L. (2003) · Urologic Clinics of North America · doi:10.1016/s0094-0143(03)00023-5 · Cited by 46
Szponar, A., Zubakov, D., Pawlak, J., Jauch, A. S., & Kovács, G. (2008) · International Journal of Cancer · doi:10.1002/ijc.24180 · Cited by 42
Molecular methods for the diagnosis of cancer
Cairns, P., & Sidransky, D. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00006-2 · Cited by 39
Self-citationMethylation patterns in human androgen receptor gene and clonality analysis.
Jang, S. J., & Mao, L. (2000) · PubMed · Cited by 32
Identification of novel VHL targets that are associated with the development of renal cell carcinoma
Abdulrahman, M., Maina, E. N., Morris, M. R., Zatyka, M., Raval, R. R., Banks, R. E., Wiesener, M. S., Richards, F. M., Johnson, C. M., Latif, F., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209932 · Cited by 21
Genetic Basis of Bilateral Renal Cancer: Implications for Evaluation and Management
Linehan, W. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.0045 · Cited by 20
Cited by
Achrol, A. S., Rennert, R. C., Anders, C., Soffietti, R., Ahluwalia, M. S., Nayak, L., Peters, S., Arvold, N. D., Harsh, G. R., Steeg, P. S., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0055-y · Cited by 1,034
Becht, E., de Reyniès, A., Giraldo, N. A., Pilati, C., Buttard, B., Lacroix, L., Selves, J., Sautès-Fridman, C., Laurent-Puig, P., & Fridman, W. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2879 · Cited by 590
Hammers, H. J., Plimack, E. R., Infante, J. R., Rini, B. I., McDermott, D. F., Lewis, L. D., Voss, M. H., Sharma, P., Pal, S. K., Razak, A. R. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.72.1985 · Cited by 505
The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design
Ling, Y., Hao, Z.-Y., Liang, D., Zhang, C.-L., Liu, Y.-F., & Wang, Y. (2021) · Drug Design, Development and Therapy · doi:10.2147/dddt.s329547 · Cited by 414
Rini, B. I., Campbell, S. C., & Rathmell, W. K. (2006) · Current Opinion in Oncology · doi:10.1097/01.cco.0000219260.60714.c4 · Cited by 379
Metadata
- Authors
- Cairns, P.
- Venue
- Cancer Biomarkers
- Publisher
- SAGE Publications
- Published
- 2011-10-26
- Volume
- 9
- Issue
- 1-6
- Pages
- 461-473
- ISSN
- 1574-0153 (ISSN-L)
- 1875-8592
- OpenAlex
- W1548453476
- Cited by
- 485
- References
- 85
- FWCI
- 12.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.